• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

GENOR(06998.HK)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Aug29
GENOR-B released FY2025 Q1 earnings on August 29 (BJT), actual revenue HKD 17.27 M, actual EPS HKD -0.0535
15:00
Jiahui Biopharma Reports 122% Revenue Growth to 32.2 million Yuan in H1 2025
13:35
GENOR-B released FY2025 Q2 earnings on August 29 During-Market BJT, actual revenue HKD 17.65 M, actual EPS HKD -0.0569
08:00
GENOR-B released FY2025 Semi-Annual Earnings on August 29 During-Market (BJT), Actual Revenue: HKD 34.91 M, Actual EPS: HKD -0.1127
08:00
Aug19
GENOR-B to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)
01:42
Jul11
Jiahe Biotech-B ESG Rating Dropped to B
01:13

Schedules & Filings

Schedules
Filings
Aug29
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 17.65 M, Net Income -29.7 M, EPS -0.0569

Mar30
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 102 M, Net Income 39.58 M, EPS 0.0764

Aug28
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 7.774 M, Net Income -72.24 M, EPS -0.1417

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
01721
0.320
+69.31%
+0.131
00924
0.225
+61.87%
+0.086
02436
11.760
+54.53%
+4.150
00627
0.590
+40.48%
+0.170
00076
0.179
+29.71%
+0.041
02668
0.265
+26.19%
+0.055
08368
0.300
+25.00%
+0.060
08203
0.275
+21.15%
+0.048
02513
158.600
+20.61%
+27.100
02506
97.550
+20.58%
+16.650
View More